ABCANN GLOBAL CORP COM NPV (OTCMKTS:ABCCF) is a recent breakout play in the cannabis patch that you should become familiar with. The company has put out a ton of investor awareness and investor relations material, but its most recent important press release is its announcement that it has received total proceeds of $11,895,298 from the exercise of an aggregate of 19,185,965 warrants since the closing of the Company’s acquisition of ABcann Medicinals Inc. on April 28, 2017.
According to the release, “these warrants, each of which was exercised into one ABcann common share, expired on September 9, 2017. They were originally issued under private placements completed by ABcann Medicinals in 2014 and 2015. After giving effect to the exercise of the warrants, ABcann’s current cash position stands at approximately $45 million, providing the Company with the capital necessary to expand its production.”
ABCANN GLOBAL CORP COM NPV (OTCMKTS:ABCCF) trumpets itself as one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It also obtained a sales licence on December 31, 2015.
Situated in Napanee, Ont., ABcann has spent the last two years focused on changing the face of medical cannabis.
ABcann intends to be the first company to have repeatable products in multiple continents and to provide standardized medical cannabis to the world. Its flagship facility contains proprietary plant-growing technology, combining the concepts, systems and components to produce high yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch.
According to company materials, “ABcann was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received in March 2014. The Company obtained its sales license in December 2015. ABcann’s flagship facility in Napanee, Ontario contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and enables ABcann to expand anywhere in the world and maintain consistency and quality of product. ABcann is expanding capacity in its current facility to approximately 30,000 sq ft and concurrently undertaking its expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing opportunities in Germany, Australia, Israel and other jurisdictions as well as exploring the development of multiple delivery vehicles.”
Find out when $ABCCF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, ABCCF shares have been breaking out of a lateral trading channel in recent days. Part of that may be because of industry strength. Part of it may be due to aggressive work on the investor relations side. But part of it may be the company’s recent announcement closing some new funding.
“ABcann thanks our shareholders for their continued support and confidence as we work toward expanding our facilities and increasing production. Our strong financial position, represented by our current cash position is earmarked for new construction and will facilitate the timely execution of our business plan,” said director and CEO, Aaron Keay. “The Company’s main focus in the coming months will be on the deployment of capital towards the expansion of our existing Vanluven facility and development and construction of the new Kimmett facility, as well as the pursuit of our international expansion plans.”
Recent action has seen 29% during the past month in terms of shareholder gains in the name, but that move comes in the context of a larger bearish trend. The situation may be worth watching. ABCCF has a track record that includes a number of dramatic bounces. Furthermore, the stock has benefitted from a jump in recent trading volume to the tune of just under 170% over the long run average.
Now commanding a market cap of $100M, ABCCF has a significant war chest ($26.8M) of cash on the books, which must be weighed relative to virtually no total current liabilities. ABCCF is pulling in trailing 12-month revenues of $271K. However, the company is seeing recent declines on the top-line on a sequential quarterly basis, with revenues falling at 10% as of its latest reporting period. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $ABCCF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $ABCCF, either long or short, and we have not been compensated for this article.